Crossref
A Novel Quinoxaline Derivatives Targeting Estrogen Receptor in Breast Cancer: Design, Molecular Docking and Md Simulations
International Journal of Drug Delivery Technology · 23.07.2026 · 16 (37s)
DOI: 10.25258/ijddt.16.37s.70 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 23.07.2026. Verfasst von Abitha H und 1 weiteren Autor:innen.
Abstract (Originalsprache)
.
Zitieren
APA
H, A., & Kumudha, D. (2026). A Novel Quinoxaline Derivatives Targeting Estrogen Receptor in Breast Cancer: Design, Molecular Docking and Md Simulations. International Journal of Drug Delivery Technology, 16(37s). https://doi.org/10.25258/ijddt.16.37s.70
Vancouver
H A, Kumudha D. A Novel Quinoxaline Derivatives Targeting Estrogen Receptor in Breast Cancer: Design, Molecular Docking and Md Simulations. International Journal of Drug Delivery Technology. 2026;16(37s). doi:10.25258/ijddt.16.37s.70
BibTeX
@article{H2026,
author = {H, Abitha and Kumudha, D.},
title = {A Novel Quinoxaline Derivatives Targeting Estrogen Receptor in Breast Cancer: Design, Molecular Docking and Md Simulations},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {37s},
doi = {10.25258/ijddt.16.37s.70}
}
EUVIMED